Journal
ONCOLOGY LETTERS
Volume 22, Issue 1, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2021.12798
Keywords
oral squamous cell carcinoma; nuclear factor-κ B; long non-coding RNA; fibroblasts; cancer-associated fibroblasts; platelet-derived growth factor
Categories
Funding
- National Natural Science Foundation of China [81660448, 81360401]
- Special Health Technical Personnel Training program of Yunnan, China [L-201612]
- Natural Science Foundation of Yunnan, China [2017FE468-006]
Ask authors/readers for more resources
The study revealed the involvement of lncRNA in the transformation of fibroblasts into CAFs induced by PDGF-BB, with the LURAP1L-AS1/LURAP1L/IKK/IB/NF-kappa B signaling pathway playing a crucial role in fibroblast activation induced by PDGF-BB.
The most abundant cells in the tumor microenvironment are cancer-associated fibroblasts (CAFs). They play an important role in oral squamous cell carcinoma (OSCC) angiogenesis, invasion and metastasis. Platelet-derived growth factor (PDGF)-BB has an obvious regulating effect on the formation of CAFs through binding to PDGF receptor (PDGFR)-beta, but the role of long non-coding (lnc)RNA in PDGF-BB-induced transformation of fibroblasts into CAFs remains poorly understood. Using an lncRNA ChIP, 370 lncRNA transcripts were identified to be significantly and differentially expressed between fibroblasts and PDGF-BB-induced fibroblasts, including 240 upregulated lncRNAs and 130 downregulated lncRNAs, indicating that lncRNAs are involved in the regulation of the transformation of CAFs. Previous studies have shown that the nuclear factor (NF)-kappa B signaling pathway plays an important role in the activation of CAFs. Dual-luciferase reporter assay and co-immunoprecipitation were conducted to confirm that the leucine-rich adaptor protein 1-like (LURAP1L), which is the target of lncRNA LURAP1L antisense RNA 1 (LURAP1L-AS1) had a positive regulatory effect on I-kappa B kinase (IKK)/NF-kappa B signaling. Therefore, LURAP1L-AS1 was selected and PDGF-BB was demonstrated to upregulate the expression of LURAP1L-AS1 and LURAP1L, which was reversed by a PDGFR-beta inhibitor. Subsequently, knocking down LURAP1L-AS1 suppressed the expression of PDGF-BB-induced fibroblast activation marker protein alpha-smooth muscle actin, fibroblast activation protein-alpha, PDGFR-beta and phosphorylated (p)-PDGFR-beta. IKK alpha, p-IB and p-NF-kappa B were downregulated by the knockdown of LURAP1L-AS1 and upregulated by overexpression of LURAP1L-AS1. The present study indicates that LURAP1L-AS1/LURAP1L/IKK/IB/NF-kappa B plays an important regulatory role in PDGF-BB-induced fibroblast activation and may become a potential target for the treatment of OSCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available